XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 25, 2022
Dec. 26, 2021
Dec. 27, 2020
Cash flows from operating activities:      
Net loss $ (190,441) $ (153,175) $ (141,224)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 46,471 35,549 26,851
Amortization of lease acquisition costs 93 402 344
Amortization of loan origination fees 126 95 96
Amortization of cloud computing arrangements 224 0 0
Operating lease cost 28,447 0 0
Loss on fixed asset disposal 278 107 891
Stock-based compensation 78,736 28,897 4,912
Impairment and closure costs 2,542 4,915 1,456
Non-cash restructuring charges 13,026 0 0
Deferred income tax expense 1,290 125 0
Change in fair value of contingent consideration 819 4,037 0
Change in fair value of preferred stock warrant liability 0 14,955 245
Changes in operating assets and liabilities:      
Account receivable (600) (1,557) 1,296
Tenant improvement receivables 0 (11,172) (2,928)
Inventory (480) (283) 211
Prepaid expenses and other current assets (2,637) (8,375) 475
Operating lease liabilities (13,955) 0 0
Accounts payable (4,546) 3,045 958
Accrued payroll and benefits (8,013) 2,829 2,278
Accrued expenses 5,732 (1,555) 8,520
Gift card and loyalty liability 177 (498) (946)
Other noncurrent liabilities (458) 0 0
Deferred rent liability 0 17,130 6,213
Net cash used in operating activities (43,169) (64,529) (90,352)
Cash flows from investing activities:      
Purchase of property and equipment (96,889) (84,511) (48,146)
Purchase of intangible assets (5,376) (8,264) (8,748)
Acquisition, net of cash acquired 0 (3,340) (791)
Security and landlord deposits 242 253 30
Lease acquisition costs 0 (1,686) (750)
Net cash used in investing activities (102,023) (97,548) (58,405)
Cash flows from financing activities:      
Repayment on long term debt 0 0 (15,000)
Proceeds from long term debt 0 0 15,000
Proceeds from preferred stock issuance, net of issuance costs 0 113,811 0
Proceeds from stock option exercise 4,758 26,028 2,145
Payment of loan origination fees (126) 0 0
Proceeds from exercise of common stock warrants 0 119 0
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs 0 384,692 0
Proceeds from issuance of Series F warrants in connection with the initial public offering 0 1,803 0
Proceeds from related party loan 0 5,158 0
Net cash provided by financing activities 4,632 531,611 2,145
Net (decrease) increase in cash and cash equivalents and restricted cash (140,560) 369,534 (146,612)
Cash and cash equivalents and restricted cash—beginning of year 472,299 102,765 249,377
Cash and cash equivalents and restricted cash—end of year 331,739 472,299 102,765
Supplemental disclosure of cash flow:      
Cash paid for interest 0 0 383
Non-cash investing and financing activities:      
Purchase of property and equipment accrued in accounts payable and accrued expenses 7,980 2,389 469
Acquisition non-cash consideration 0 30,704 0
Initial liability associated with contingent consideration 0 16,440 0
Conversion of redeemable convertible preferred stock to common stock in connection with public company offering 0 614,496 0
Series F warrants      
Non-cash investing and financing activities:      
Reclassification of warrant liability to APIC in connection with initial public offering 0 6,580 0
Series J Warrants      
Non-cash investing and financing activities:      
Reclassification of warrant liability to APIC in connection with initial public offering $ 0 $ 16,979 $ 0